Zachary Brennan | in-Pharma Technologist.com | 11-Mar-2014 Nearly a quarter of drugs made in Jammu & Kashmir and 10% of those produced in Himachal Pradesh are substandard according to new testing data published by CDSCO. Read full article Continue reading
Sama, on behalf of Jan Swasthya Abhiyan (JSA), published a policy brief, which outlines the key features of the current healthcare system, based upon which it makes a set of feasible policy proposals to move ahead. Continue reading
Letter to Hon’ble Minister of Health and Family Welfare, raising issues and concerns related to assisted reproductive technologies (ARTs) and surrogacy: To, Shri Ghulam Nabi Azad, Hon’ble Minister of Health and Family Welfare, Government of India, New Delhi Dear Shri Ghulam… Continue reading
The information brief presents and discusses various facets and issues related to surrogacy in India. It is meticulously structured in a way that it draws on Sama’s engagement through research, which reflects the documented ground realities vis-à-vis the practice of… Continue reading
Sama carried out an assessment along with Chaupal in four districts of Chhattisgarh, including Raipur, Koriya, Kabeerdham and Mahasamund, from January 2014 to October 2014. The assessment aimed to map, document and understand existing practices with regard to the response… Continue reading
2013 | Berne Declaration, Sama This research report is based on a study that Sama along with Berne Declaration, an independent Swiss NGO, undertook in 2012- 2013 to explore the conduct of clinical trials sponsored by Swiss pharmaceutical companies in… Continue reading
